TCL Archive Afinitor and Exemestane More Than Doubles PFS, Reduces Progression Risk by 57 Percent September 30, 2011
TCL Archive PI Defends NCI’s National Lung Screening Trial As “Rigorous” Randomized Trial. November 3, 2006